Previous 10 | Next 10 |
2024-05-08 08:30:00 ET Summary Pfizer Inc.'s COVID vaccine revenue plunged to $354M in Q1, indicating a dramatic reset. It should help Pfizer potentially outperform moving ahead as it laps easier comps. Pfizer is a fundamentally strong stock with a dividend yield of almost 6%....
2024-05-08 07:16:00 ET Healthcare doesn't get the hype that other industries -- say, technology -- get. However, there arguably isn't an industry more important to humankind's well-being. That's especially true in the United States, the world's most lucrative healthcare market -- a multi-tr...
2024-05-08 07:06:13 ET More on AstraZeneca AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript AstraZeneca invests $140M in Cellectis, raising stake to 44% ...
2024-05-07 21:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-07 20:26:14 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2024-05-07 16:16:50 ET More on Pfizer, Sarepta Pfizer: Solid Earnings, But We're Not Out Of The Woods Yet Pfizer: Ignore The Dead Cat Bounce Pfizer Stock: Finally The Market Is Waking Up Pfizer hires Citi healthcare analyst Baum to lead strategy and innovatio...
2024-05-07 04:32:13 ET Summary Pfizer released a solid set of quarterly earnings last week, with $14.9bn topline revenues and adjusted EPS of $0.82. The Pharma giant earned >$100bn from its COVID vaccine and antiviral in 2021, 2022 and 2023, yet still maintains >$60bn of lon...
2024-05-06 13:43:19 ET More on Pfizer Pfizer: Ignore The Dead Cat Bounce Pfizer Stock: Finally The Market Is Waking Up Pfizer Inc. (PFE) Q1 2024 Earnings Call Transcript Pharma R&D productivity seen improving for the first time in years - Deloitte ...
2024-05-06 11:08:32 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions BioNTech Q1 2024 Earn...
2024-05-06 08:06:11 ET Summary Pfizer's Q1 earnings release showed strong performance, beating revenue estimates and providing positive guidance for FY 2024. However, secular weaknesses such as declining operating margins and the need for new products to replace expiring patents p...
News, Short Squeeze, Breakout and More Instantly...
2024-07-24 10:13:00 ET If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are unsure about how strong its long-term prospects are, which ...
2024-07-24 10:08:31 ET DENVER, Colo., Jul 24, 2024 ( 247marketnews.com )- Sangamo Therapeutics, Inc. (Nasdaq: SGMO ) expounded on Pfizer’s (NYSE: PFE ) positive topline results from their Phase 3 AFFINE trial (NCT04370054) evaluating giroctocogene fitelparvovec, an invest...
2024-07-24 09:00:21 ET Pfizer Inc. (PFE) declaring a stock dividend of $0.42 per share on Ex-Date : July 25, 2024. Shareholders on record as of July 26, 2024 are eligible for the dividend. The payment date is scheduled for September 03, 2024, and the declaration was officially made ...